Long-term follow-up confirms the favourable prognostic impact of high numbers of tumour infiltrating CD3 T-cells in follicular lymphoma patients treated by rituximab-maintenance regimen. - Université de Lille
Article Dans Une Revue British Journal of Haematology Année : 2023

Long-term follow-up confirms the favourable prognostic impact of high numbers of tumour infiltrating CD3 T-cells in follicular lymphoma patients treated by rituximab-maintenance regimen.

Dates et versions

hal-04607323 , version 1 (10-06-2024)

Identifiants

Citer

Camille Laurent, Maria Flores, Loïc Chartier, Sarah Huet, Christopher R. Bolen, et al.. Long-term follow-up confirms the favourable prognostic impact of high numbers of tumour infiltrating CD3 T-cells in follicular lymphoma patients treated by rituximab-maintenance regimen.. British Journal of Haematology, 2023, British Journal of Haematology, 202, pp.686-689. ⟨10.1111/bjh.18881⟩. ⟨hal-04607323⟩
13 Consultations
0 Téléchargements

Altmetric

Partager

More